Table of Contents
List of Tables 4
List of Figures 5
Report Guidance 6
GlobalData Clinical Trials Report Coverage 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Five Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by G7 Countries: Proportion of Lupus Nephritis to Immunology Clinical Trials 17
Clinical Trials by Phase in G7 Countries 18
Clinical Trials in G7 Countries by Trial Status 19
Clinical Trials by E7 Countries: Proportion of Lupus Nephritis to Immunology Clinical Trials 20
Clinical Trials by Phase in E7 Countries 21
Clinical Trials in E7 Countries by Trial Status 22
Clinical Trials by Phase 24
In Progress Trials by Phase 25
Clinical Trials by Trial Status 26
Clinical Trials by End Point Status 28
Subjects Recruited Over a Period of Time 29
Clinical Trials by Sponsor Type 30
Prominent Sponsors 31
Top Companies Participating in Lupus Nephritis Therapeutics Clinical Trials 33
Prominent Drugs 35
Latest Clinical Trials News on Lupus Nephritis 36
Nov 11, 2019: Genentech’s Gazyva (obinutuzumab), in Combination With Standard of Care, More Than Doubles the Percentage of Lupus Nephritis Patients Achieving Complete Renal Response, Compared To Standard of Care Alone 36
Nov 08, 2019: Apellis Presents First Data on APL-2 in C3 Glomerulopathy at ASN Kidney Week 36
Nov 06, 2019: Equillium to present new data and insights on the CD6-ALCAM pathway in Lupus Nephritis at ACR 2019 37
Oct 16, 2019: Aurinia reports last patient study visit in Aurora phase 3 lupus nephritis study and provides update on ATM facility 37
Oct 11, 2019: Apellis to present data on APL-2 in complement 3 Glomerulopathy at ASN Kidney Week 2019 38
Oct 01, 2019: Equillium Announces Initiation of the EQUALISE Phase 1b Clinical Trial of Itolizumab for Patients with Lupus Nephritis and Provides Business Update 38
Sep 25, 2019: Omeros announces publication of study showing that inhibition of MASP-2, the key enzyme of the complement system’s Lectin Pathway, protects against renal injury caused by Proteinuria 39
Sep 19, 2019: Roche receives FDA breakthrough status for lupus nephritis drug 39
Clinical Trial Profile Snapshots 40
Appendix 176
Abbreviations 176
Definitions 176
Research Methodology 177
Secondary Research 177
About GlobalData 178
Contact Us 178
Source 179
Lupus Nephritis Therapeutics, Global, Clinical Trials by Region, 2019* 8
Lupus Nephritis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 10
Lupus Nephritis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11
Lupus Nephritis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019* 12
Lupus Nephritis Therapeutics Clinical Trials, Europe, Top Five Countries, 2019* 13
Lupus Nephritis Therapeutics Clinical Trials, North America, Top Countries, 2019* 14
Lupus Nephritis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2019* 15
Lupus Nephritis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2019* 16
Proportion of Lupus Nephritis to Immunology Clinical Trials, G7 Countries (%), 2019* 17
Lupus Nephritis Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 18
Lupus Nephritis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 19
Proportion of Lupus Nephritis to Immunology Clinical Trials, E7 Countries (%), 2019* 20
Lupus Nephritis Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 21
Lupus Nephritis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 23
Lupus Nephritis Therapeutics, Global, Clinical Trials by Phase, 2019* 24
Lupus Nephritis Therapeutics, Global, Clinical Trials In Progress by Phase 2019* 25
Lupus Nephritis Therapeutics, Global, Clinical Trials by Trial Status, 2019* 27
Lupus Nephritis Therapeutics Clinical Trials, Global, by End Point Status, 2019* 28
Lupus Nephritis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 29
Lupus Nephritis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019* 30
Lupus Nephritis Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 32
Lupus Nephritis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 34
Lupus Nephritis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 35
List of Figures
Lupus Nephritis Therapeutics, Global, Clinical Trials by Region (%), 2019* 8
Lupus Nephritis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9
Lupus Nephritis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11
Lupus Nephritis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019* 12
Lupus Nephritis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019* 13
Lupus Nephritis Therapeutics Clinical Trials, North America, Top Countries (%), 2019* 14
Lupus Nephritis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2019* 15
Lupus Nephritis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2019* 16
Proportion of Lupus Nephritis to Immunology Clinical Trials, G7 Countries (%), 2019* 17
Lupus Nephritis Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 18
Lupus Nephritis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 19
Proportion of Lupus Nephritis to Immunology Clinical Trials, E7 Countries (%), 2019* 20
Lupus Nephritis Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 21
Lupus Nephritis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 22
Lupus Nephritis Therapeutics, Global, Clinical Trials by Phase (%), 2019* 24
Lupus Nephritis Therapeutics, Global, Clinical Trials In Progress by Phase, 2019* 25
Lupus Nephritis Therapeutics, Global, Clinical Trials by Trial Status, 2019* 26
Lupus Nephritis Therapeutics Clinical Trials, Global, by End Point Status, 2019* 28
Lupus Nephritis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 29
Lupus Nephritis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019* 30
Lupus Nephritis Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 31
Lupus Nephritis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 33
Lupus Nephritis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 35
GlobalData Methodology 177
【免責事項】
https://www.marketreport.jp/reports-disclaimer